Picture of Redcare Pharmacy NV logo

RDC Redcare Pharmacy NV News Story

0.000.00%
de flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMid CapNeutral

Brief: Redcare Pharmacy Q2 Preliminary Sales At Eur 560 Mln, Up 33% YoY

July 4 (Reuters) - REDCARE PHARMACY NV  RDC.DE :
    * STRONG ACCELERATION OF E-RX SALES IN GERMANY FOR REDCARE
PHARMACY, FROM 7% GROWTH IN Q1 TO 37% IN Q2.
    * TOTAL SALES REACHED EUR 560M IN Q2, UP 33% YEAR OVER YEAR
    * Q2 NON-RX SALES TOTALED EUR 390M, STEADY CONTINUATION OF
FAST
GROWTH, UP 21% YEAR OVER YEAR
    * ACTIVE CUSTOMER BASE EXPANDED TO 11.6M, UP 0.4M IN Q2 AND
1.4M
IN ONE YEAR
    * REDCARE PHARMACY'S TOTAL GROUP SALES INCREASED 33.3% TO
EUR 560
MILLION (Q2 2023: EUR 420 MILLION)
    * YEAR-TO-DATE SALES TO EUR 1,120 MILLION AND GROWTH TO
41.4% (H1
2023: EUR 792 MILLION)

Source text for Eikon:  ID:nEQ8nm1ZSa 
Further company coverage:  RDC.DE 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Redcare Pharmacy NV

See all news